Research
Hormonal
Smaller adipocytes resulting from weight loss exhibit higher insulin sensitivity and enhanced nutrient clearance capacity, which signals energy depletion to the brain and promotes the storage of ingested energy.
Your body's fat cells become more efficient at storing fat when they shrink. This biological efficiency makes it easier to regain weight when you eat, as your body prioritizes storing those calories over burning them.
GoodSupportsHIGH confidence
Compared with large adipocytes, small adipocytes exhibit higher insulin-stimulated glucose uptake, higher levels of glucose oxidation and a lower sensitivity to antilipolytic action of insulin... These adaptive responses in the adipocyte prime the tissue to replete energy stores when nutrients once again become readily available.
Why this rating
Supported by multiple cited studies on adipocyte metabolism in humans and rodents.
Source
The role for adipose tissue in weight regain after weight loss
Paul S. MacLean et al. · Obesity Reviews · 2015
DOI 10.1111/obr.12255
narrative_reviewCited 204×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Weight loss induces adipocyte shrinkage and metabolic adaptations that create a persistent biological drive to regain weight by increasing nutrient clearance efficiency and lowering energy expenditure, creating an 'energy gap' that promotes overeating.Good
- Weight loss reduces circulating levels of leptin and insulin disproportionately to fat mass loss, signaling energy depletion to the hypothalamus and increasing appetite.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →